Across TCGA pan-cancer cohorts, ZNF812P Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated ZNF812P data layer compared with 20 for mass-spec protein.
The strongest signal is observed in stomach adenocarcinoma (STAD), where higher ZNF812P Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated ZNF812P expression acts as an unfavorable survival marker.
STAD, SCLC, and HNSC are the cancer types where ZNF812P Mutation most reproducibly stratifies survival.
Mutation survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.